Avalo Therapeutics, Inc.
$927.80M- Market cap
- $1.03B
- Debt
- +-$5.17M
- Cash
- −$98.34M
Capital structure 101% equity / -1% debt · EV / Revenue 15725.35x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AVTX · current priceP/S 17479.74x
$19.23Latest market snapshot
Implied fair value · at COLM's multiple
$0.00100.0% below market
0.00 AVTX revenue / share×0.87x COLM P/S=$0.00
Market $19.23Implied $0.00
COLM · current priceP/S 0.87x
$57.72Latest market snapshot
Implied fair value · at AVTX's multiple
$1,160,013.842,009,626.0% above market
66.36 COLM revenue / share×17479.74x AVTX P/S=$1,160,013.84
Market $57.72Implied $1,160,013.84